Institutional investors hold a majority ownership of GILD through the 88.02% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CARNEGIE ASSET MANAGEMENT FONDSM... Bought 4.6 Million shares of Gilead Sciences
CITIGROUP GLOBAL MARKETS INC. (B... Bought 4.2 Million shares of Gilead Sciences
BNP PARIBAS ARBITRAGE SNC Bought 2.3 Million shares of Gilead Sciences